Journal of Biological Chemistry · 2011 · 138 citations · 62 references
Life SciencesGeneticsMolecular BiologyCancer GeneticsDna RepairMolecular OncologyChromatinDna Damage SignalingDna LigaseDna LigationNon-homologous End JoiningDeletionsDna End JoiningHuman Dna Ligase IiiHuman Dna Ligase IvNon-homologous End Joining DefectsNonhomologous End JoiningNonhomologous End Joining DefectsNonhomologous End Joining Deficiency
Recent studies have implicated a poorly defined alternative pathway of nonhomologous end joining (alt-NHEJ) in the generation of large deletions and chromosomal translocations that are frequently observed in cancer cells. Here, we describe an interaction between two factors, hMre11/hRad50/Nbs1 (MRN) and DNA ligase IIIα/XRCC1, that have been linked with alt-NHEJ. Expression of DNA ligase IIIα and the association between MRN and DNA ligase IIIα/XRCC1 are altered in cell lines defective in the major NHEJ pathway. Most notably, DNA damage induced the association of these factors in DNA ligase IV-deficient cells. MRN interacts with DNA ligase IIIα/XRCC1, stimulating intermolecular ligation, and together these proteins join incompatible DNA ends in a reaction that mimics alt-NHEJ. Thus, our results provide novel mechanistic insights into the alt-NHEJ pathway that not only contributes to genome instability in cancer cells but may also be a therapeutic target.
62
Human CtIP promotes DNA end resection
Alessandro A. Sartori, Claudia Lukas, Julia Coates et al. · Nature · 2007 · 1.3K citations · Full text
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Minli Wang, Wei‐Zhong Wu, Wenqi Wu et al. · Nucleic Acids Research · 2006 · 800 citations · Full text
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway
Dae‐Sik Lim, Seong‐Tae Kim, Bo Xu et al. · Nature · 2000 · 778 citations